Who We Are

Rifetech s.r.o. specialises in research and development in the sphere of the medical potential of a pulsed EM field. The initial development phase of Rifetech s.r.o. was partially undertaken with the support of European grant funds in the field of innovation under the auspices of the Ministry of Industry and Trade. An expert team led by doc. Ing. Vladimír Holcman, Ph.D., Ing. Roberta Macků, Ph.D., and Ing. Tomáš Trčka, Ph.D. from the Institute of Physics, in cooperation with biologist RNDr. Dagmar Jančová, Ph.D., charged itself with the task of developing a new methodology to account for rapidly changing trends in technology and medicine, influenced by factors such as an increase in antibiotic resistance, the risk of further pandemics, the annual increase in civilisation diseases, and the resulting demand for effective and non-invasive procedures without the need for excessive drug treatment. Successful simulations, calculations, and modulations laid the foundations for technology that, thanks to an innovative combination of frequency protocols, pulsed EM field, and specifically-connected plasma emitter, has considerable potential

to induce a biological reaction in the organism with therapeutic effects. This biological response in the organism can occur at immunomodulation, compensation, neuromodulation, and revitalisation level. We have now moved on to the phase of clinically testing this unique technology, which, inter alia, has its foundations in the long-overlooked and suppressed work of Dr. Royal Raymond Rife. We are therefore faced with the enormous challenge of being the first company in the world to transfer this vision into official medical technology.

We have been working with doctors and professional therapists for many years now, particularly in Germany, Benelux, and Switzerland. For several years, we have also been a strategic partner to the Loprais Team, which regularly uses our ever-improving technology to support concentration and performance and accelerate regeneration during the unbelievably demanding Dakar Rally.